These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 19289423)
1. Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In. Liu X; Wang Y; Nakamura K; Kawauchi S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ J Nucl Med; 2009 Apr; 50(4):582-90. PubMed ID: 19289423 [TBL] [Abstract][Full Text] [Related]
2. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture. Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463 [TBL] [Abstract][Full Text] [Related]
3. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker. Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ J Nucl Med; 2007 Nov; 48(11):1845-52. PubMed ID: 17978353 [TBL] [Abstract][Full Text] [Related]
4. Auger-mediated cytotoxicity of cancer cells in culture by an 125I-antisense oligomer delivered as a three-component streptavidin nanoparticle. Liu X; Nakamura K; Wang Y; Cheng D; Liang M; Xiao N; Chen L; Rusckowski M; Hnatowich DJ J Biomed Nanotechnol; 2010 Apr; 6(2):153-7. PubMed ID: 20738069 [TBL] [Abstract][Full Text] [Related]
5. Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation. Liu Y; Cheng D; Liu X; Liu G; Dou S; Xiao N; Chen L; Rusckowski M; Hnatowich DJ Nucl Med Biol; 2012 Jan; 39(1):101-7. PubMed ID: 21958854 [TBL] [Abstract][Full Text] [Related]
6. Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery. Liu X; Wang Y; Nakamura K; Kubo A; Hnatowich DJ Cancer Gene Ther; 2008 Feb; 15(2):126-32. PubMed ID: 18084241 [TBL] [Abstract][Full Text] [Related]
7. In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles. Wang Y; Liu X; Nakamura K; Chen L; Rusckowski M; Hnatowich DJ Cancer Biother Radiopharm; 2009 Oct; 24(5):573-8. PubMed ID: 19877887 [TBL] [Abstract][Full Text] [Related]
8. Evidence of antisense tumor targeting in mice. Nakamura K; Fan C; Liu G; Gupta S; He J; Dou S; Kubo A; Rusckowski M; Hnatowich DJ Bioconjug Chem; 2004; 15(6):1475-80. PubMed ID: 15546217 [TBL] [Abstract][Full Text] [Related]
9. A nanoparticle for tumor targeted delivery of oligomers. Liu X; Wang Y; Hnatowich DJ Methods Mol Biol; 2011; 764():91-105. PubMed ID: 21748635 [TBL] [Abstract][Full Text] [Related]
10. Tumor delivery of antisense oligomer using trastuzumab within a streptavidin nanoparticle. Wang Y; Liu X; Chen L; Cheng D; Rusckowski M; Hnatowich DJ Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1977-86. PubMed ID: 19572130 [TBL] [Abstract][Full Text] [Related]
11. Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics. Zhang YM; Tung CH; He J; Liu N; Yanachkov I; Liu G; Rusckowski M; Vanderheyden JL Nucl Med Biol; 2006 Feb; 33(2):263-9. PubMed ID: 16546682 [TBL] [Abstract][Full Text] [Related]
12. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides. Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904 [TBL] [Abstract][Full Text] [Related]
13. Her2/neu small interfering RNA delivered in culture by a streptavidin nanoparticle. Liu X; Nakamura K; Cheng D; Peng C; Xiao N; Liu Y; Chen L; Rusckowski M; Hnatowich DJ Curr Drug Deliv; 2012 Jul; 9(4):431-6. PubMed ID: 22520071 [TBL] [Abstract][Full Text] [Related]
14. A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length. He J; Liu G; Zhang S; Vanderheyden JL; Liu N; Liu C; Zhang Y; Gupta S; Rusckowski M; Hnatowich DJ Bioconjug Chem; 2003; 14(5):1018-23. PubMed ID: 13129406 [TBL] [Abstract][Full Text] [Related]
15. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305 [TBL] [Abstract][Full Text] [Related]
16. Ionic strength-sensitive pullulan acetate nanoparticles (PAN) for intratumoral administration of radioisotope: ionic strength-dependent aggregation behavior and (99m)Technetium retention property. Park KH; Song HC; Na K; Bom HS; Lee KH; Kim S; Kang D; Lee DH Colloids Surf B Biointerfaces; 2007 Sep; 59(1):16-23. PubMed ID: 17532195 [TBL] [Abstract][Full Text] [Related]
17. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept. He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145 [TBL] [Abstract][Full Text] [Related]
18. Optical antisense imaging of tumor with fluorescent DNA duplexes. Liu X; Wang Y; Nakamura K; Liu G; Dou S; Kubo A; Rusckowski M; Hnatowich DJ Bioconjug Chem; 2007; 18(6):1905-11. PubMed ID: 17939728 [TBL] [Abstract][Full Text] [Related]
19. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor. Liu G; He J; Dou S; Gupta S; Rusckowski M; Hnatowich DJ Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1115-23. PubMed ID: 16133391 [TBL] [Abstract][Full Text] [Related]